Devicemakers Should Prepare for an FDA Focus on Raw Data During Inspections

The GMP Letter
A A
FDA investigators increasingly are shifting from “top down” inspections focused on policies to “bottom up” inspections that focus on raw data, an industry insider says.

To View This Article:

Login

Subscribe To The GMP Letter